Cargando…

Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh(2)(CH(3)COO)(4) with Cysteine and Its Derivatives

[Image: see text] We have combined results from several spectroscopic techniques to investigate the aerobic reactions of Rh(2)(AcO)(4) (AcO(–) = CH(3)COO(–)) with l-cysteine (H(2)Cys) and its derivatives d-penicillamine (3,3′-dimethylcysteine, H(2)Pen), with steric hindrance at the thiol group, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalilehvand, Farideh, Enriquez Garcia, Alejandra, Niksirat, Pantea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644637/
https://www.ncbi.nlm.nih.gov/pubmed/31457864
http://dx.doi.org/10.1021/acsomega.7b01090
_version_ 1783437299951861760
author Jalilehvand, Farideh
Enriquez Garcia, Alejandra
Niksirat, Pantea
author_facet Jalilehvand, Farideh
Enriquez Garcia, Alejandra
Niksirat, Pantea
author_sort Jalilehvand, Farideh
collection PubMed
description [Image: see text] We have combined results from several spectroscopic techniques to investigate the aerobic reactions of Rh(2)(AcO)(4) (AcO(–) = CH(3)COO(–)) with l-cysteine (H(2)Cys) and its derivatives d-penicillamine (3,3′-dimethylcysteine, H(2)Pen), with steric hindrance at the thiol group, and N-acetyl-l-cysteine (H(2)NAC), with its amino group blocked. Previous investigations have shown that antitumor active dirhodium(II) carboxylates may irreversibly inhibit enzymes containing a thiol group at or near their active sites. Also, cysteine, the only thiol-containing proteinogenic amino acid, interacts in vivo with this class of antitumor compounds, but structural information on the products of such reactions is lacking. In the present study, the reactions of Rh(2)(AcO)(4) and H(2)L were carried out in aqueous solutions at the pH of mixing (acidic) and at physiological pH, using the different mole ratios 1:2, 1:4, and 1:6, which resulted in the same products in increasing yields. Electrospray ionization mass spectrometry (ESI-MS) indicates formation of dimeric [Rh(III)(2)Pen(4)](2–) or oligomeric {Rh(III)(2)L(4)}(n) (L = Cys, NAC) complexes with bridging thiolate groups. Analyses of Rh K edge extended X-ray absorption fine structure (EXAFS) data reveal 3–4 Rh–S and 2–3 Rh–(N/O) bonds around six-coordinated Rh(III) ions at mean distances of 2.33 ± 0.02 and 2.09 ± 0.02 Å, respectively. In the N-acetyl-l-cysteine compound, the Rh(III)···Rh(III) distance 3.10 ± 0.02 Å obtained from the EXAFS spectrum supports trithiolate bridges between the Rh(III) ions, as was also found when using glutathione as ligand. In the cysteine and penicillamine complexes, double thiolate bridges join the Rh(III) ions, with the nonbridging Cys(2–) and Pen(2–) ligands in tridentate chelating (S,N,O) mode, which is consistent with the Δδ(C) = 7.3–8.4 ppm shift of the COO(–) signal in their carbon-13 cross polarization magic angle spinning (CPMAS) NMR spectra. For the penicillamine complex, the 2475.6 eV peak in its S K edge X-ray absorption near edge structure (XANES) spectrum shows partial oxidation, probably caused by peroxide generated from reduction of dissolved O(2), of thiolato to sulfenato (S=O) groups, which were also identified by ESI-MS for all three {Rh(III)(2)L(4)}(n) compounds.
format Online
Article
Text
id pubmed-6644637
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-66446372019-08-27 Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh(2)(CH(3)COO)(4) with Cysteine and Its Derivatives Jalilehvand, Farideh Enriquez Garcia, Alejandra Niksirat, Pantea ACS Omega [Image: see text] We have combined results from several spectroscopic techniques to investigate the aerobic reactions of Rh(2)(AcO)(4) (AcO(–) = CH(3)COO(–)) with l-cysteine (H(2)Cys) and its derivatives d-penicillamine (3,3′-dimethylcysteine, H(2)Pen), with steric hindrance at the thiol group, and N-acetyl-l-cysteine (H(2)NAC), with its amino group blocked. Previous investigations have shown that antitumor active dirhodium(II) carboxylates may irreversibly inhibit enzymes containing a thiol group at or near their active sites. Also, cysteine, the only thiol-containing proteinogenic amino acid, interacts in vivo with this class of antitumor compounds, but structural information on the products of such reactions is lacking. In the present study, the reactions of Rh(2)(AcO)(4) and H(2)L were carried out in aqueous solutions at the pH of mixing (acidic) and at physiological pH, using the different mole ratios 1:2, 1:4, and 1:6, which resulted in the same products in increasing yields. Electrospray ionization mass spectrometry (ESI-MS) indicates formation of dimeric [Rh(III)(2)Pen(4)](2–) or oligomeric {Rh(III)(2)L(4)}(n) (L = Cys, NAC) complexes with bridging thiolate groups. Analyses of Rh K edge extended X-ray absorption fine structure (EXAFS) data reveal 3–4 Rh–S and 2–3 Rh–(N/O) bonds around six-coordinated Rh(III) ions at mean distances of 2.33 ± 0.02 and 2.09 ± 0.02 Å, respectively. In the N-acetyl-l-cysteine compound, the Rh(III)···Rh(III) distance 3.10 ± 0.02 Å obtained from the EXAFS spectrum supports trithiolate bridges between the Rh(III) ions, as was also found when using glutathione as ligand. In the cysteine and penicillamine complexes, double thiolate bridges join the Rh(III) ions, with the nonbridging Cys(2–) and Pen(2–) ligands in tridentate chelating (S,N,O) mode, which is consistent with the Δδ(C) = 7.3–8.4 ppm shift of the COO(–) signal in their carbon-13 cross polarization magic angle spinning (CPMAS) NMR spectra. For the penicillamine complex, the 2475.6 eV peak in its S K edge X-ray absorption near edge structure (XANES) spectrum shows partial oxidation, probably caused by peroxide generated from reduction of dissolved O(2), of thiolato to sulfenato (S=O) groups, which were also identified by ESI-MS for all three {Rh(III)(2)L(4)}(n) compounds. American Chemical Society 2017-09-27 /pmc/articles/PMC6644637/ /pubmed/31457864 http://dx.doi.org/10.1021/acsomega.7b01090 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle Jalilehvand, Farideh
Enriquez Garcia, Alejandra
Niksirat, Pantea
Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh(2)(CH(3)COO)(4) with Cysteine and Its Derivatives
title Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh(2)(CH(3)COO)(4) with Cysteine and Its Derivatives
title_full Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh(2)(CH(3)COO)(4) with Cysteine and Its Derivatives
title_fullStr Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh(2)(CH(3)COO)(4) with Cysteine and Its Derivatives
title_full_unstemmed Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh(2)(CH(3)COO)(4) with Cysteine and Its Derivatives
title_short Reactions of Antitumor Active Dirhodium(II) Tetraacetate Rh(2)(CH(3)COO)(4) with Cysteine and Its Derivatives
title_sort reactions of antitumor active dirhodium(ii) tetraacetate rh(2)(ch(3)coo)(4) with cysteine and its derivatives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644637/
https://www.ncbi.nlm.nih.gov/pubmed/31457864
http://dx.doi.org/10.1021/acsomega.7b01090
work_keys_str_mv AT jalilehvandfarideh reactionsofantitumoractivedirhodiumiitetraacetaterh2ch3coo4withcysteineanditsderivatives
AT enriquezgarciaalejandra reactionsofantitumoractivedirhodiumiitetraacetaterh2ch3coo4withcysteineanditsderivatives
AT niksiratpantea reactionsofantitumoractivedirhodiumiitetraacetaterh2ch3coo4withcysteineanditsderivatives